CGP invests in innovations across the Life Sciences industry.

Our target technologies are breakthroughs with unmet clinical need, strong IP protection, and the appeal to become a must-have for strategic players. We completed many successful transactions with a superior return on invested capital in partnerships with the leading US and EU venture groups.

Investment Focus: Disruptive, scientifically validated treatments with blockbuster commercial potential and exit horizon of 3-5 years.